We are live on ! Find out more
CANY

Caxton Associates (New York) Portfolio holdings

AUM $3.18B
1-Year Est. Return 54.49%
This Fund
S&P 500
This Quarter Est. Return
+26.3%
1 Year Est. Return
+54.49%
3 Year Est. Return
+73.91%
5 Year Est. Return
+212.89%
10 Year Est. Return
+632.2%
AUM
$1.15B
AUM Growth
+$601M
Cap. Flow
+$483M
Cap. Flow %
42.15%
Top 10 Hldgs %
60.26%
Holding
693
New
300
Increased
46
Reduced
89
Closed
249

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$82.8M
2
JPM icon
JPMorgan Chase
JPM
+$54.1M
3
BABA icon
Alibaba
BABA
+$51.1M
4
DE icon
Deere & Co
DE
+$31.8M
5
JD icon
JD.com
JD
+$14.3M

Sector Composition

Rank Sector Weight
1 Technology 14%
2 Energy 7.45%
3 Consumer Discretionary 7.05%
4 Utilities 4.19%
5 Healthcare 3.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLR
676
DELISTED
CONTINENTAL RESOURCES INC.
CLR
-163,488
Closed -$1.25M
CCXI
677
DELISTED
ChemoCentryx, Inc.
CCXI
-6,783
Closed -$273K
MIC
678
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
-10,784
Closed -$272K
CERN
679
DELISTED
Cerner Corp
CERN
-17,797
Closed -$1.12M
CONE
680
DELISTED
CyrusOne Inc Common Stock
CONE
-5,016
Closed -$310K
INFO
681
DELISTED
IHS Markit Ltd. Common Shares
INFO
-5,570
Closed -$334K
SC
682
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
-20,011
Closed -$278K
COR
683
DELISTED
Coresite Realty Corporation
COR
-7,558
Closed -$876K
CVA
684
DELISTED
Covanta Holding Corporation
CVA
-26,717
Closed -$228K
XEC
685
DELISTED
CIMAREX ENERGY CO
XEC
-102,740
Closed -$1.73M
MYOK
686
DELISTED
MyoKardia, Inc. Common Stock
MYOK
-11,845
Closed -$555K
MNTA
687
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
-20,659
Closed -$562K
AGN
688
DELISTED
Allergan plc
AGN
-5,174
Closed -$916K
CYOU
689
DELISTED
Changyou.com Limited American Depositary Share
CYOU
-46,855
Closed -$501K
FTSV
690
DELISTED
Forty Seven, Inc. Common Stock
FTSV
-2,424
Closed -$231K
RARX
691
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
-9,049
Closed -$434K
DISH
692
DELISTED
DISH Network Corp.
DISH
-15,914
Closed -$318K
CIT
693
DELISTED
CIT Group Inc.
CIT
-29,886
Closed -$516K

Similar funds

Caxton Associates (New York)'s Q2 2020 Portfolio in Review

As of Q2 2020, Caxton Associates (New York) held 693 positions worth $1.15B, up 111% from $544M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Caxton Associates (New York) deployed $483M of net new capital in Q2 2020, opening 300 new positions and adding to 46 existing holdings. Its largest new stake was Hess: 1,011,414 shares worth $52.4M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 27% a quarter earlier, followed by Energy and Consumer Discretionary.

On the sell side, the largest reduction was JPMorgan Chase, an estimated $54.1M trimmed.

  • Caxton Associates (New York)'s largest Q2 2020 buy was Hess: 1,011,414 shares worth $52.4M.
  • Caxton Associates (New York) added most to SPDR Gold Trust in Q2 2020, an estimated $403M increase.
  • Caxton Associates (New York)'s biggest Q2 2020 reduction was JPMorgan Chase, cutting an estimated $54.1M.
  • Caxton Associates (New York) fully exited Microsoft in Q2 2020, selling an estimated $82.8M.
  • Caxton Associates (New York)'s ten largest holdings make up 60% of its $1.15B portfolio in Q2 2020.
  • Caxton Associates (New York) opened 300 new positions and closed 249 in Q2 2020.
  • Caxton Associates (New York)'s portfolio value rose 111% quarter-over-quarter to $1.15B.

Based on Caxton Associates (New York)'s 13F filing for Q2 2020, filed 14 Aug 2020.